Organ procurement organization OneLegacy today announced a landmark healthcare initiative for Southern California. The nonprofit group launched the first in-house Ex Vivo Lung Perfusion program at a western recovery center. To achieve this milestone, OneLegacy partnered with global medical technology leaders XVIVO and Perfusion Solutions.
Consequently, the Azusa facility now houses the advanced XPS™ clinical hardware. Specialized perfusion experts from Perfusion Solution will operate the machinery around the clock.
This innovative technology keeps donated lungs functioning outside the human body. Meanwhile, clinical teams safely evaluate and preserve the tissue for future surgeries. By expanding the assessment window, the program makes more donor organs available for medical centers. Therefore, the setup significantly helps save patients awaiting critical operations.
Expanding the Safe Window for Organ Transplants
Traditionally, time constraints limit distant organ delivery. Now, this protocol gives transplant teams additional hours to carefully evaluate questionable tissues.
“At OneLegacy, everything we do is driven by a single purpose: honoring every donor’s gift by helping save as many lives as possible,” said Prasad Garimella, CEO of OneLegacy. “For nearly 50 years, we’ve worked alongside hospitals and transplant centers to advance organ donation through innovation and implementing this technology represents another important step forward. This program gives us new opportunities to maximize the gift of donation and help more patients receive the lifesaving transplants they desperately need.”
Maximizing Lifesaving Gifts Through Advanced Innovation
The machine circulates a specialized solution and oxygen through the lungs. As a result, doctors can observe performance metrics in a controlled environment. This extended preservation window provides greater logistical flexibility during surgery coordination. Consequently, organs can travel a farther distance to reach compatible recipients.
“Building the future of transplantation requires more than innovation alone. It requires strong partnerships that expand access and strengthen the entire transplant ecosystem,” said XVIVO CEO Christoffer Rosenblad. “At XVIVO, we are driven by one vision: nobody should die waiting for a new organ. Together with OneLegacy and Perfusion Solution, we are helping turn that vision into meaningful progress.”
“At Perfusion Solution, we are proud to support OneLegacy and XVIVO in bringing this important EVLP capability to the West Coast,” said Jon Bohannen, Chief Donor Service Officer and Executive Vice President of Perfusion Solution. “OneLegacy’s leadership in creating an OPO-centered regional hub, combined with XVIVO’s advanced lung perfusion technology, reflects the kind of collaboration the transplant field needs. By providing specialized perfusion expertise and clinical support, we can help transplant teams better evaluate donor lungs, improve coordination, and honor more donor gifts by creating more opportunities for lifesaving transplantation.”
Currently, over a thousand patients in the United States await lung transplants. This new regional hub now allows over 70 transplant centers to utilize this medical technology. Ultimately, the program ensures each organ donor’s gift has the best chance of successful transplantation.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
